Plexon Inc Releases Exceptional 2014 Growth
January 16, 2015
DALLAS, TEXAS — (January 16, 2015) – Plexon Inc, the leader in advanced hardware and software solutions for neuroscience and behavioral research, releases outstanding fiscal year 2014 annual sales growth of 30% yielding the strongest year the company has experienced to date.
According to Plexon’s President, Harvey W. Wiggins, “We are most pleased with the sales numbers as they are a direct reflection of how well our products are meeting the current needs of researchers around the world. In our tireless pursuit to be the neuroscience researcher’s most dependable partner, we continue to push the boundaries of innovation while expanding existing product features and applications – and we seem to be getting it right.”
The growth was spread across all three of Plexon’s primary businesses. The demand for the OmniPlex® D Neural Data Acquisition System grew significantly as the strength in lower channel count recording systems was compounded by growing commitments to higher channel counts. Plexon expects that trend to continue supported by late last year’s launch of the 512 channel OmniPlex System incorporating the new Digital Headstage Processor (DHP) subsystem and multiplexing, digital headstages.
The CineLAB™ Behavior Research product line offering sophisticated digital video recording, tracking and analysis functionality exceed all expectations. Most notably, sales of CinePlex® Systems – the CineLAB product specifically developed to work in synchrony with neural data acquisition – more than doubled, likely indicating an increased value placed on fully synchronized offerings.
Finally, the PlexBright® Optogenetics Stimulation System continued to experience anticipated growth in its third year. Sales of both the 4 Channel Optogenetic Controller with Radiant™ software (supporting both LEDs and lasers) as well as components supporting optogenetics research with freely behaving animals drove the lion’s share of the business. Plexon closed its 31st year in business with record sales. Its three decades of experience and dedication to researchers continues to pay off for customers and for the company. Plexon is privately held with a fiscal year ending December 31.
About Plexon Inc
Plexon is a pioneer and leading innovator of custom, high performance data acquisition, behavior and analysis solutions specifically designed for scientific research. We collaborate with and supply thousands of customers including the most prestigious neuroscience laboratories around the globe driving new frontiers in areas including basic science, brain-machine interfaces (BMI), neurodegenerative diseases, addictive behaviors and neuroprosthetics. Plexon offers integrated solutions for in vivo neurophysiology, optogenetics and behavioral research — backed by its industry-leading commitment to quality and customer support. plexon.com.